José Luis Lamas

Long‐term safety and efficacy of the anti‐tissue factor pathway inhibitor marstacimab in participants with severe haemophilia: Phase II study results

Johnny Mahlangu, José Luis Lamas, Juan Cristóbal Morales et al. · British Journal of Haematology · 2022 · 58 citations · Full text

Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: a prospective, controlled, multicentre phase I/III study in previously treated patients with severe (FIX level <1%) or moderately severe (FIX level ≤2%) haemophilia B

Jerzy Windyga, Toshko Lissitchkov, Oleksandra Stasyshyn et al. · Haemophilia · 2013 · 48 citations

A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia

Johnny Mahlangu, José Luis Lamas, Juan Cristóbal Morales et al. · British Journal of Haematology · 2022 · 41 citations · Full text

Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome?

B. Sopeña, Pérez Rodríguez, A. Rivera et al. · Lupus · 2010 · 22 citations

Haemophilia care in Latin America: Assessment and perspectives

Apsara Boadas, Margareth C. Ozelo, María Helena Solano et al. · Haemophilia · 2018 · 14 citations